Cargando…
Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods
BACKGROUND: Information regarding effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant strains on clinical manifestations and outcomes of coronavirus disease 2019 (COVID-19) in pregnant women is limited. METHODS: A retrospective observational study was conducted using the...
Autores principales: | Shoji, Kensuke, Tsuzuki, Shinya, Akiyama, Takayuki, Matsunaga, Nobuaki, Asai, Yusuke, Suzuki, Setsuko, Iwamoto, Noriko, Funaki, Takanori, Yamada, Masaki, Ozawa, Nobuaki, Yamaguchi, Koushi, Miyairi, Isao, Ohmagari, Norio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464469/ https://www.ncbi.nlm.nih.gov/pubmed/36103949 http://dx.doi.org/10.1016/j.jiac.2022.09.005 |
Ejemplares similares
-
Clinical characteristics of COVID-19 in hospitalized children during the Omicron variant predominant period
por: Shoji, Kensuke, et al.
Publicado: (2022) -
Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis
por: Shoji, Kensuke, et al.
Publicado: (2023) -
Comparison of the clinical characteristics and outcomes of COVID-19 in children before and after the emergence of Delta variant of concern in Japan
por: Shoji, Kensuke, et al.
Publicado: (2022) -
Regional trends in the use of steroids and favipiravir for COVID-19 treatment
por: Asai, Yusuke, et al.
Publicado: (2023) -
1147. Regional Trends in Favipiravir and Steroid Use in the Treatment of COVID-19
por: Asai, Yusuke, et al.
Publicado: (2022)